Propylon is a pharmaceutical consulting firm based in Ljubljana, Slovenia, specializing in EU market entry for non-European pharmaceutical and supplement manufacturers. Unlike traditional regulatory-only consultancies, Propylon uses a commercial-first approach: assessing market viability, pricing, distribution, and competitive landscape before committing to a regulatory pathway. Core engagements are delivered in 2 to 3 weeks and include market entry strategy, product viability assessment, patent and exclusivity landscape analysis, and execution roadmaps. Propylon serves manufacturers from Asia, Latin America, Africa, and other non-EU regions seeking to register and commercialize pharmaceutical products in the European Union.

EU market entry is a commercial decision with regulatory constraints. Not the other way around.

A structured approach that starts with commercial viability. Regulatory strategy follows. For pharmaceutical manufacturers ready to enter Europe with clarity, not guesswork.

Request an assessment

Propylon is a pharmaceutical consulting firm specializing in EU market entry.

We work with non-European pharmaceutical and supplement manufacturers to assess whether EU market entry makes commercial sense, and if it does, to build the regulatory and operational path to get there. Most consultancies start with regulation. We start with commercial viability.

See how we work →

The EU remains one of the most commercially attractive pharmaceutical markets globally

27+
Countries accessible through a single regulatory strategy
€1–10M+
Annual revenue potential per product, per market cluster
12–18mo
Realistic timeline to first revenue with the right approach

Products registered in Europe command higher pricing in the Middle East, Latin America, and parts of Asia. EU entry is a strategic lever, not just a market.

We reverse the typical EU entry sequence. Most companies start with regulatory. We start with commercial viability.

01
Commercial viability first

Market sizing, pricing, distribution, and competitive landscape assessed before any regulatory commitment.

02
Regulatory + compliance aligned

Regulatory route and manufacturing compliance aligned to the commercial strategy.

03
Execution planning

Dossier readiness, partner selection, timelines, costs, and a clear go/no-go decision.

If you are considering EU market entry, we can provide an initial assessment within one week.

No commitment required. We start with a focused conversation about your product, your timeline, and your commercial objectives. If EU entry makes sense, we outline the path. If it does not, we tell you directly.

Get in touch